Healthcare provider profile · identity verified

Vincent E Perkowski, D.O.

Family Practice · MASSILLON, OH · NPI 1316940208

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	237	50
Atorvastatin Calcium	Atorvastatin Calcium	227	62
Lisinopril	Lisinopril	225	56
Metoprolol Succinate	Metoprolol Succinate	211	50
Alprazolam	Alprazolam	200	36
Amlodipine Besylate	Amlodipine Besylate	196	52
Metformin Hcl	Metformin Hcl	175	42
Levothyroxine Sodium	Levothyroxine Sodium	172	47
Albuterol Sulfate Hfa	Albuterol Sulfate	156	44
Pantoprazole Sodium	Pantoprazole Sodium	138	37
Losartan Potassium	Losartan Potassium	136	39
Gabapentin	Gabapentin	134	35
Rosuvastatin Calcium	Rosuvastatin Calcium	129	32
Tizanidine Hcl	Tizanidine Hcl	122	24
Furosemide	Furosemide	109	31
Tamsulosin Hcl	Tamsulosin Hcl	106	25
Hydrochlorothiazide	Hydrochlorothiazide	94	18
Metoprolol Tartrate	Metoprolol Tartrate	85	18
Montelukast Sodium	Montelukast Sodium	78	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	77	21
Buspirone Hcl	Buspirone Hcl	76	18
Eliquis	Apixaban	76	18
Lorazepam	Lorazepam	76	11
Famotidine	Famotidine	69	18
Trazodone Hcl	Trazodone Hcl	68	21
Pravastatin Sodium	Pravastatin Sodium	64	17
Zolpidem Tartrate	Zolpidem Tartrate	64	suppressed
Glimepiride	Glimepiride	61	15
Potassium Chloride	Potassium Chloride	61	16
Glipizide	Glipizide	60	11
Escitalopram Oxalate	Escitalopram Oxalate	58	14
Jardiance	Empagliflozin	57	17
Clonazepam	Clonazepam	54	suppressed
Simvastatin	Simvastatin	54	17
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Meloxicam	Meloxicam	51	16
Carvedilol	Carvedilol	48	19
Methylprednisolone	Methylprednisolone	47	40
Ondansetron Hcl	Ondansetron Hcl	47	11
Fluoxetine Hcl	Fluoxetine Hcl	45	11
Spironolactone	Spironolactone	45	12
Sertraline Hcl	Sertraline Hcl	44	suppressed
Pregabalin	Pregabalin	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	22
Oxybutynin Chloride Er	Oxybutynin Chloride	40	11
Bupropion Xl	Bupropion Hcl	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	13
Sumatriptan Succinate	Sumatriptan Succinate	37	suppressed
Topiramate	Topiramate	36	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Promethazine Hcl	Promethazine Hcl	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Azithromycin	Azithromycin	33	25
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	14
Tramadol Hcl	Tramadol Hcl	33	11
Lovastatin	Lovastatin	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	30	suppressed
Ibuprofen	Ibuprofen	30	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Ozempic	Semaglutide	27	suppressed
Cefdinir	Cefdinir	26	22
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Cephalexin	Cephalexin	25	23
Fluconazole	Fluconazole	25	15
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Prednisone	Prednisone	25	19
Lansoprazole	Lansoprazole	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Diazepam	Diazepam	21	suppressed
Mounjaro	Tirzepatide	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Atenolol	Atenolol	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Amoxicillin	Amoxicillin	16	16
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Mupirocin	Mupirocin	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Valsartan	Valsartan	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Nystatin	Nystatin	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Acebutolol Hcl	Acebutolol Hcl	11	suppressed
Baclofen	Baclofen	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error